Chen-Hsin Kuo

Mr. Chen-Hsin Kuo

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
PCPei-Yi Chu
Pei-Yi Chu
YTYen-Dun Tzeng
Yen-Dun Tzeng
Yi-Han ChiuYi-Han Chiu
Yi-Han Chiu
HLHung-Yu Lin
Hung-Yu Lin
CKChen-Hsin Kuo
Chen-Hsin Kuo
Chia-Jung LiChia-Jung Li
Chia-Jung Li
E3 ubiquitin-linked enzyme MARCH5, also known as membrane-associated circular finger 5, is an enzyme encoded by the human MARCH5 gene. The main objective of this study was to visualize the prognosis of MARCH5 in breast cancer and to determine the relationship between MARCH5 expression and tumor immunity. MARCH5 expression was significantly higher in several cancers, including breast cancer (BRCA), compared with corresponding normal tissues. Not only was high MARCH5 expression associated with poorer overall survival, but also MARCH5 expression was positively correlated with the number of tumor-infiltrating immune cells in BRCA malignant tissues. Furthermore, MARCH5 expression showed a strong correlation with various immune markers of BRCA, suggesting its role in regulating tumor immunity. MARCH5 is a useful prognostic biomarker in several cancers, and its expression is highly correlated with tumor immune cell infiltration, and increased MARCH5 expression may serve as a new biomarker for BRCA diagnosis and prognosis.

Verified
Journal Article
Open access
PDF file
CCChin-Chuan Chen
Chin-Chuan Chen
JHJu-Sui Huang
Ju-Sui Huang
TWTong-Hong Wang
Tong-Hong Wang
CKChen-Hsin Kuo
Chen-Hsin Kuo
CWChia-Jen Wang
Chia-Jen Wang
YLYann-Lii Leu
Yann-Lii Leu
Effective DNA repair enables cancer cells to survive DNA damage induced by chemotherapeutic or radiotherapeutic treatments. Therefore, inhibiting DNA repair pathways is a promising therapeutic strategy for increasing the efficacy of such treatments. In this study, we found that dihydrocoumarin (DHC), a flavoring agent, causes deficiencies in double-stand break (DSB) repair and prolonged DNA damage checkpoint recovery in yeast. Following DNA damage, Rad52 recombinase was revealed to be inhibited by DHC, which results in deficiencies in DSB repair and prolonged DNA damage checkpoint recovery. The deletion of RPD3, a class I histone deacetylase (HDAC), was found to mimic DHC-induced suppression of Rad52 expression, suggesting that the HDAC inhibitor activity of DHC is critical to DSB repair and DNA damage sensitivity. Overall, our findings delineate the regulatory mechanisms of DHC in DSB repair and suggest that it might potentially be used as an inhibitor of the DNA repair pathway in human cells.